Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06RLU
|
||||
Former ID |
DNCL003692
|
||||
Drug Name |
ACT-128800
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Psoriasis [ICD9: 696; ICD10:L40] | Phase 2 | [522598] | ||
Company |
Actelion
|
||||
Structure |
Download2D MOL |
||||
Formula |
C23H25ClN2O4S
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sphingosine 1-phosphate receptor 1 | Target Info | Modulator | [543701] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.